ADIPOQ and Obesity: Obesity not only increases the risk of GDM but also exacerbates insulin resistance and chronic inflammation by influencing adipokines (e.g., leptin and adiponectin) secreted by adipose tissue, thereby promoting the onset of GDM (39, 40).